Sevelamer Carbonate
Brand name: Sevelamer Carbonate
Rank #167 of 500 drugs by total cost
$95.6M
Total Cost
277,192
Total Claims
$95.6M
Total Cost
6,867
Prescribers
$345
Cost per Claim
59,506
Beneficiaries
423,070
30-Day Fills
$14K
Avg Cost/Provider
40
Avg Claims/Provider
About Sevelamer Carbonate
Sevelamer Carbonate (sold as Sevelamer Carbonate) was prescribed 277,192 times by 6,867 Medicare Part D providers in 2023, costing the program $95.6M. At $345 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 164 | Guselkumab (Tremfya) | $97.1M | 7,102 |
| 165 | Levetiracetam (Levetiracetam) | $96.1M | 1,723,736 |
| 166 | Oxycodone Myristate (Xtampza Er) | $96.1M | 141,266 |
| 167 | Sevelamer Carbonate (Sevelamer Carbonate) | $95.6M | 277,192 |
| 168 | Aripiprazole Lauroxil (Aristada) | $93.3M | 31,120 |
| 169 | Trazodone Hcl (Trazodone Hcl) | $92.6M | 7,273,528 |
| 170 | Insulin Glargine/Lixisenatide (Soliqua 100-33) | $92.5M | 82,886 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology